Accendra Health names Kenneth Gardner-Smith as next CEO; Scott Lloyd as Chief Commercial Officer

ACCENDRA HEALTH INC/VA/

Gardner-Smith, Board member since Mar 2022, to assume CEO early Q4 2026; succeeds retiring Edward Pesicka.
Offer Letter: $1.0M base salary, 130% target bonus, $6M equity grant (25% RSU, 25% PSU, 50% cash PSU), $650K sign-on bonus.
Lloyd to become Chief Commercial Officer effective Oct 5, 2026; ex-Evergreen Nephrology, co-founder of Extrakare.
Pesicka remains CEO until transition, then advisor; Gardner-Smith steps down from two board committees.

item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward A. Pesicka

Director

ACH · ACCENDRA HEALTH INC/VA/

Filed: September 17, 2026, 6:35 AM ET

Mr. Pesicka will remain in the role of President and CEO until Mr. Gardner-Smith assumes the role, at which point Mr. Pesicka will also retire from the Board of Directors, as previously announced.

Departed

Edward A. Pesicka

President and Chief Executive Officer

ACH · ACCENDRA HEALTH INC/VA/

Successor: Kenneth Gardner-Smith
Filed: September 17, 2026, 6:35 AM ET

He will succeed Edward A. Pesicka, who previously announced his intent to retire in August.

Appointed

Kenneth Gardner-Smith

President and Chief Executive Officer

ACH · ACCENDRA HEALTH INC/VA/

Filed: September 17, 2026, 6:35 AM ET

On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward A. Pesicka departed as Director at ACCENDRA HEALTH INC/VA/.

Action: retire
Role: Director

Exact text from the filing

Mr. Pesicka will remain in the role of President and CEO until Mr. Gardner-Smith assumes the role, at which point Mr. Pesicka will also retire from the Board of Directors, as previously announced.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward A. Pesicka departed as President and Chief Executive Officer at ACCENDRA HEALTH INC/VA/.

Action: retire
Role: President and Chief Executive Officer

Exact text from the filing

He will succeed Edward A. Pesicka, who previously announced his intent to retire in August.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Gardner-Smith was named as President and Chief Executive Officer at ACCENDRA HEALTH INC/VA/.

Action: named
Role: President and Chief Executive Officer

Exact text from the filing

On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.

View on SEC.gov

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001104659-26-108405

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.